Skip to content
OpenCapital
Get started

Medifast MED Optavia Segment — Equity compensation

Similar metrics at other companies

Venu Holding logo
VENUEquity Compensation
$3.84M+27.7%
BNC
BNCRetail and Industry — Equity-based compensation
-$34K—
Arrowhead Research logo
ARWROperating Segment — Stock compensation
$8.37M+2.9%
Sarepta Therapeutics, Inc. logo
SRPTAll Other Segments — Stock-Based Comp
$29.4M-29.0%
Crescent Energy logo
CRGYReportable Segment — Equity-Based Compensation Expense
$24.5M-8.0%
Symbotic Inc. logo
SYMOperation services — Share-Based Payment Arrangement, Expense
$1.17M+227%

Other financials

Income statement

See full
Revenue$76.0M-34.3%
Gross profit$51.8M-38.6%
Operating income-$3.3M-161%
Net income-$2.1M-175%
EPS (diluted)-$0.19-171%

Balance sheet

See full
Cash & equivalents$71.5M-22.0%
Total debt$16.1M+10.2%
Total equity$197.7M-6.3%
Total assets$252.0M-10.0%

Cash flow

See full
Operating cash flow$260.0K-92.4%
CapEx$1.1M-28.0%
Free cash flow-$836.0K-144%

Valuation

See full
Market cap$121.87M-17.4%
Enterprise value$66.44M+12.8%
P/S0.4×0.0×

Profitability

See full
Gross margin70.1%-3.8pp
Operating margin-4.7%-7.0pp
Net margin-5.8%-8.1pp
FCF margin5%-9.3pp

Returns & leverage

See full
Return on equity-9.8%-20.1pp
Debt / equity0.1×0.0×
Current ratio4.8×+1.3×

Where this comes from

Reported directly by Medifast in its filing.

Tagged under the XBRL concept us-gaap:AllocatedShareBasedCompensationExpense.

The official record: Medifast’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Medifast's optavia segment — equity compensation.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Medifast's optavia segment — equity compensation?
Medifast (MED) reported optavia segment — equity compensation of $1.9M in Q1 2026.
How has Medifast's optavia segment — equity compensation changed year-over-year?
Medifast's optavia segment — equity compensation decreased by 1.8% year-over-year, from $1.93M to $1.9M.
What is the long-term trend for Medifast's optavia segment — equity compensation?
Over 3 years (2022 to 2025), Medifast's optavia segment — equity compensation has grown at a -11.4% compound annual growth rate (CAGR), from $11.05M to $7.68M.
What does optavia segment — equity compensation mean?
Reflects the non-cash expense associated with share-based payments granted to employees and coaches within the Optavia segment. This metric is used to assess the impact of equity-based incentive programs on the segment's overall profitability.